Huan Xiao
Chengdu, 610075, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Habitual Spectacle-Corrected Distance Visual Acuity and Axial Elongation in School-Based Myopia Screening: A Retrospective Cohort Study.
Journal: Healthcare (Basel, Switzerland)
Published: June 02, 2026
Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 02, 2025
A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy.
Journal: Signal transduction and targeted therapy
Published: October 12, 2024
Dynamic O-GlcNAcylation coordinates etoposide-triggered tumor cell pyroptosis by regulating p53 stability.
Journal: The Journal of biological chemistry
Published: September 28, 2024
Numerical simulation study on the characteristics and mechanism of ultrasonic cavitation cleaning of crude oil sediments.
Journal: Ultrasonics sonochemistry
Published: September 24, 2024
Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 17, 2024
Selective Covalent Inhibiting JNK3 by Small Molecules for Parkinson's Diseases.
Journal: Angewandte Chemie (International ed. in English)
Published: June 12, 2024
Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors.
Journal: Journal of medicinal chemistry
Published: April 13, 2024
A promising small molecule binding pocket in class B GPCRs: expanding potential for drug development.
Journal: Signal transduction and targeted therapy
Published: August 09, 2023
Small molecules targeting protein-protein interactions for cancer therapy.
Journal: Acta pharmaceutica Sinica. B
Published: March 08, 2023
Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease.
Journal: Journal of medicinal chemistry
Published: January 17, 2023
Last Updated: 09/26/2026